Silk fibroins modify the atmospheric low temperature plasma-treated poly (3-hydroxybutyrate-co-3-hydroxyhexanoate) film for the application of cardiovascular tissue engineering

Huaxiao Yang, Min Sun, Ping Zhou, Luanfeng Pan, Chungen Wu

.

DOI: 10.4236/jbise.2010.312149                

Abstract

Tissue engineered scaffold is one of the hopeful therapies for the patients with organ or tissue damages. The key element for a tissue engineered scaffold material is high biocompatibility. Herein the poly (3-hydroxybutyrate-co-3-hydroxyhexanoate) (PHBHHx) film was irradiated by the low temperature atmospheric plasma and then coated by the silk fibroins (SF). After plasma treatment, the surface of PHBHHx film became rougher and more hydrophilic than that of original film. The experiment of PHBHHx flushed by phosphate buffer solution (PBS) proves that the coated SF shows stronger immobilization on the plasma-treated film than that on the untreated film. The cell viability assay demonstrates that SF-coated PHBHHx films treated by the plasma significantly supports the proliferation and growth of the human smooth muscle cells (HSMCs). Furthermore, the scanning electron microscopy and hemotoylin and eosin (HE) staining show that HSMCs formed a cell sub-monolayer and secreted a large amount of extracellular matrix (ECM) on the films after one week's culture. The silk fibroins modify the plasma-treated PHBHHx film, providing a material potentially applicable in the cardiovascular tissue engi-neering.

Keywords

Biocompatible; Cardiovascular Tissue Engineering; Low Temperature Plasma; Poly (3-Hydroxybutyrate-Co-3-Hydroxyhexanoate) (PHBHHx); Silk Fibroin

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	Armentano, I. (2009) Role of PLLA plasma surface modification in the interaction with human marrow stromal cells. Journal of Applied Polymer Science, 114, 3602-3611.
[2]	Chen, G., Zhou, P., Mei, N., Chen, X., Shao, Z.Z., Pan, L.F. and Wu, C.G. (2004) Silk fibroin modified porous poly (E-caprolactone) scaffold for human fibroblast culture in vitro. Journal of Materials Science-Materials in Medicine, 15, 671-677.
[3]	Chen, G.Q. and Wu, Q. (2005) The application of polyhy- droxyalkanoates as tissue engineering materials. Bioma- terials, 26, 6565-6578.
[4]	Dumitrascu, N., Borcia C. and Borcia G. (2008) Control of the blood-polymer interface by plasma treatment. Journal of Biomedical Materials Research Part B-Applied Biomaterials, 87B, 364-373.
[5]	Dumitrascu, N., Borcia, G., Apetroaei, N. and Popa, G. (2002) Roughness modification of surfaces treated by a pulsed dielectric barrier discharge. Plasma Sources Science & Technology, 11, 127-134.
[6]	Hersel, U., Dahmen, C. and Kessler, H. (2003) RGD modified polymers: biomaterials for stimulated cell adhesion and beyond. Biomaterials, 24, 4385-4415.
[7]	Hoerstrup, S.P. (2000) Functional living trileaflet heart valves grown in vitro. Circulation, 102, 44-49.
[8]	Khang, G., Kim, S.W., Cho, J.C., Rhee, J.M., Yoon, S.C. and Lee, H.B. (2001) Preparation and characterization of poly (3-hy-droxybutyrate-co-3-hydroxyvalerate) microspheres for the sustained release of 5-fluorouracil. Bio-Medical Materials and Engineering, 11, 89-103.
[9]	Kim, M.S., Shin, Y.N., Cho, M.H., Kim, S.H., Kim, S.K., Cho, Y.H., Khang, G., Lee, I.W. and Lee, H.B. (2007) Adhesion behavior of human bone marrow stromal cells on differentially wettable polymer surfaces. Tissue Engineering, 13, 2095-2103.
[10]	Lampin, M., WarocquierClerout, R., Legris, C, Degrange, M. and SigotLuizard, M.F. (1997) Correlation between substratum roughness and wettability, cell adhesion, and cell migration. Journal of Biomedical Materials Research, 36, 99-108.
[11]	Langer, R. and Vacanti, J.P. (1993) Tissue Engineering. Science, 260, 920-926.
[12]	Lee, S.Y. (1996) Bacterial polyhydroxyalkanoates. Bio- technology and Bioengineering, 49, 1-14.
[13]	Li, X.T., Zhang, Y. and Chen, G.Q. (2008a) Nanofibrous polyhy- droxyalkanoate matrices as cell growth supporting materials. Biomaterials, 29, 3720-3728.
[14]	Li, X.T., Sun, J., Chen, S. and Chen, G.Q. (2008b) In vitro investigation of maleated poly (3-hydroxybutyrate- co-3-hydroxyhexanoate) for its biocompatibility to mou- se fibroblast L929 and human microvascular endothelial cells. Journal of Biomedical Materials Research Part A, 87A, 832-842.
[15]	Li, Z.G., Lin, H., Ishii, N., Chen, G.Q. and Inoue, Y. (2007) Study of enzymatic degradation of microbial copolyesters consisting of 3-hydroxybutyrate and mdium- chain-length 3-hydroxyalkanoates. Polymer Degradation and Stability, 92, 1708-1714.
[16]	Mei, N., Chen, G., Zhou, P., Chen, X., Shao, Z.Z., Pan, L.F. and Wu C.G. (2005) Biocompatibility of poly (epsilon-caprolac-tone) scaffold modified by chitosan - The fibroblasts proliferation in vitro. Journal of Biomaterials Applications, 19, 323-339.
[17]	Mei, N., Zhou, P., Pan, L.F., Chen, G., Wu, C.G., Chen, X., Shao, Z.Z. and Chen, G.Q. (2006) Biocompatibility of poly (3-hy-droxybutyrate-co-3-hydroxyhexanoate) modified by silk fibroin. Journal of Materials Science- Materials in Medicine, 17, 749-758.
[18]	Niklason, L.E., Gao, J., Abbott, W.M., Hirschi, K.K., Houser, S., Marini, R. and Langer, R. (1999) Functional arteries grown in vitro. Science, 284, 489-493.
[19]	Ostrikov, K. and Murphy, A.B. (2007) Plasma-aided nanofabrication: Where is the cutting edge? Journal of Physics D-Applied Physics, 40, 2223-2241.
[20]	Robinson, D.E., Marson, A., Short, R.D., Buttle, D.J., Day, A.J., Parry, K.L., Wiles, M., Highfield, P., Mistry, A. and Whittle, J.D. (2008) Surface gradient of functional heparin. Advanced Materials, 20, 1166-1169.
[21]	Shangguan, Y.Y., Wang, Y.W., Wu, Q. and Chen, G.Q. (2006) The mechanical properties and in vitro biodegradation and biocompatibility of UV-treated poly (3-hydroxybutyrate-co-3-hydroxyhexanoate). Biomaterials, 27, 2349-2357.
[22]	Shen, H., Hu, X.X., Bei, J.Z., Wang, S.G. (2008) The immobilization of basic fibroblast growth factor on plasma-treated poly (lactide-co-glycolide). Biomaterials, 29, 2388-2399.
[23]	Shen, H., Hu, X.X., Yang, F., Bel, J.Z. and Wang, S.G. (2007) Combining oxygen plasma treatment with anchorage of cationized gelatin for enhancing cell affinity of poly (lactide-co-glycolide). Biomaterials, 28, 4219-4230.
[24]	Shishatskaya, E.I., Voinova, O.N., Goreva, A.V., Mogilnaya, O.A. and Volova, T.G. (2008) Biocompatibility of polyhydroxybutyrate microspheres: in vitro and in vivo evaluation. Journal of Materials Science-Materials in Medicine, 19, 2493-2502.
[25]	Siow, K.S., Britcher, L., Kumar, S. and Griesser, H.J. (2006) Plasma methods for the generation of chemically reactive surfaces for biomolecule immobilization and cell colonization — A review. Plasma Processes and Polymers, 3, 392-418.
[26]	Sodian, R., Hoerstrup, S.P., Sperling, J.S., Daebritz, S., Martin, D.P., Moran, A.M., Kim, B.S., Schoen, F.J., Vacanti, J.P. and Mayer, J.E. (2000) Early in vivo experience with tissue-engineered trileaflet heart valves. Circulation, 102, 22-29.
[27]	Sun, M., Zhou, P., Pan, L.F., Liu, S. and Yang, H.X. (2009) Enhanced cell affinity of the silk fibroin-modified PHBHHx material. Journal of Materials Science-Materials in Medicine, 20, 1743-1751.
[28]	Tamada, Y. and Ikada, Y. (1993) Cell-adhesion to plasma-treated polymer surfaces. Polymer, 34, 2208-2212.
[29]	Wang, Y.W., Wu, Q., Chen, J.C. and Chen, G.Q. (2005) Evaluation of three-dimensional scaffolds made of blends of hydroxyapatite and poly (3-hydroxybutyrate-co-3- hydroxy-hexanoate) for bone reconstruction. Biomaterials, 26, 899-904.
[30]	Wu, Q., Wang, Y. and Chen, G.Q. (2009) Medical Application of Microbial Biopolyesters Polyhydroxyalkanoates. Artificial Cells Blood Substitutes and Biotechnology, 37, 1-12.
[31]	Xin, X.J., Hussain, M. and Mao, J.J. (2007) Continuing different- tiation of human mesenchymal stem cells and induced chondrogenic and osteogenic lineages in electrospun PLGA nanofiber scaffold. Biomaterials, 28, 316-325.
[32]	Yang, M., Zhu, S.S., Chen, Y., Chang, Z.J., Chen, G.Q., Gong, Y.D., Zhao, N.M. and Zhang, X.F. (2004) Studies on bone marrow stromal cells affinity of poly (3- hydroxybutyrate-co-3-hydroxyhexanoate). Biomaterials, 25, 1365-1373.
[33]	Zhang, D.M., Cui, F.Z., Luo, Z.S., Lin, Y.B., Zhao, K. and Chen, G.Q. (2000) Wettability improvement of bacterial polyhy-droxyalkanoates via ion implantation. Surface & Coatings Technology, 131, 350-354.
[34]	Zhang, J.C., Wu, L.B., Jing, D.Y. and Ding, J.D. (2005) A comparative study of porous scaffolds with cubic and spherical macropores. Polymer, 46, 4979-4985.
[35]	Zhang, Y., Zhou, P., Pan, L.F., Xie, S.Z., Sun, M. and Li, W.T. (2007) Growth of human smooth muscle cells on the silk fibroin modified-polyhydroxyalkanoate scaffold. Acta Chimica Sinica, 65, 2935-2940.
[36]	Zhao, K., Deng, Y., Chen, J.C. and Chen, G.Q. (2003) Polyhy-droxyalkanoate (PHA) scaffolds with good mechanical properties and biocompatibility. Biomaterials, 24, 1041-1045.